Molecule Details
| InChIKey | BJWFIOSIGHDXLF-QBHOUYDASA-N |
|---|---|
| Compound Name | (2S)-2-[(1-{[3-cyclohexyl-1-(1,3-thiazol-5-yl)propoxy]carbonyl}-5-(2-methylphenyl)-1,2,3,6-tetrahydropyridin-4-yl)formamido]-4-(methylsulfanyl)butanoic acid |
| Canonical SMILES | CSCC[C@H](NC(=O)C1=C(c2ccccc2C)CN(C(=O)OC(CCC2CCCCC2)c2cncs2)CC1)C(=O)O |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 9.15 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile